11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      National Trend of Uroflowmetry, Urodynamic Study and Cystoscopy Considering the Change in the Population Structure in Korea from 2010 to 2015

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Although lower urinary tract symptoms (LUTS) show a higher prevalence with age, few studies have reported the trend of these examination tools including uroflowmetry, urodynamic study and cystoscopy.

          Methods

          We evaluated the trend of performance of uroflowmetry, urodynamic study and cystoscopy by using National Health Insurance Data from 2010 to 2015. Primary outcome findings included cumulative number of patients per year, cumulative age-standardized patient rate per year and per age group, and correlation between the number of patients per year and the percentage of population per year in each age group.

          Results

          The overall trend for frequency of uroflowmetry and cystoscopy showed an increasing pattern ( P < 0.001, respectively) while the trend for frequency of urodynamic study showed a decreasing pattern ( P < 0.001). After age standardization, the overall trend showed similar results. Correlation between the number of patients per year and the percentage of population per year showed a positive correlation in the 50s age group and the above 70s age group ( P = 0.003 and < 0.01, respectively) on uroflowmetry and in the above 70s age group ( P < 0.01) on cystoscopy. Urodynamic study showed negative correlations in the 50s age group and the above 60s age group ( P = 0.001 and 0.01, respectively).

          Conclusion

          National trend for frequency of uroflowmetry, urodynamic study and cystoscopy showed a different trend. The increasing trend of uroflowmetry and cystoscopy was related with growth of the aged population. However, urodynamic study showed a decreasing trend regardless of the age group.

          Graphical Abstract

          Related collections

          Most cited references12

          • Record: found
          • Abstract: found
          • Article: not found

          The lifetime distribution of health care costs.

          To estimate the magnitude and age distribution of lifetime health care expenditures. Claims data on 3.75 million Blue Cross Blue Shield of Michigan members, and data from the Medicare Current Beneficiary Survey, the Medical Expenditure Panel Survey, the Michigan Mortality Database, and Michigan nursing home patient counts. Data were aggregated and summarized in year 2000 dollars by service, age, and gender. We use life table models to simulate a typical lifetime's distribution of expenditures, employing cross-sectional data on age- and sex-specific health care costs and the mortality experience of the population. We determine remaining lifetime expenditures at each age for all initial members of a birth cohort. Separately, we calculate remaining expenditures for survivors at all ages. Using cross-sectional data, the analysis holds disease incidence, medical technology, and health care prices constant, thus permitting an exclusive focus on the role of age in health care costs. Per capita lifetime expenditure is USD $316,600, a third higher for females (USD $361,200) than males (USD $268,700). Two-fifths of this difference owes to women's longer life expectancy. Nearly one-third of lifetime expenditures is incurred during middle age, and nearly half during the senior years. For survivors to age 85, more than one-third of their lifetime expenditures will accrue in their remaining years. Given the essential demographic phenomenon of our time, the rapid aging of the population, our findings lend increased urgency to understanding and addressing the interaction between aging and health care spending.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Urologic diseases in america project: benign prostatic hyperplasia.

            Benign prostatic hyperplasia (BPH), the most common benign neoplasm in American men, is a chronic condition that is associated with progressive lower urinary tract symptoms and affects almost 3 of 4 men during the seventh decade of life. Approximately 6.5 million of the 27 million white men who are 50 to 79 years old in the United States in 2000 were estimated to meet the criteria for discussing treatment. The analytical methods used to generate these results have been described previously. In 2000 approximately 4.5 million visits were made to physician offices to for a primary diagnosis of BPH and almost 8 million visits were made with a primary or secondary diagnosis of BPH. In the same year approximately 87,400 prostatectomies for BPH were performed in inpatients in nonfederal hospitals in the United States. While the number of outpatient visits for BPH increased consistently during the 1990s, there was a dramatic decrease in the use of transurethral prostatectomy, inpatient hospitalization and length of hospital stay for this condition. These trends reflect the changing face of medical management for BPH, ie increasing use of pharmacological agents and minimally invasive therapies. In 2000 the direct cost of BPH treatment was estimated to be $1.1 billion exclusive of outpatient pharmaceuticals. Given the impact that BPH has on quality of life and health care cost in millions of American men, additional research into risk factors, diagnostic and therapeutic resource use, and effectiveness and cost benefit of therapies are warranted.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Incidence of kidney, bladder, and prostate cancers in Korea: An update

              The incidence of cancer is sharply increasing. Cancer is a leading cause of death as well as a significant burden on society. The incidence of urological cancer has shown a higher than average increase and will become an important concern in the future. Therefore, an overall and accurate understanding of the incidence of urological cancer is essential. In this study, which was based on the Korea National Cancer Incidence Database, annual incident cases, age-standardized incidence rates, annual percentage change (APC), and distribution by age group were examined in kidney, bladder, and prostate cancers, respectively. From 1999 to 2011, the total number of each type of urological cancer was as follows: kidney cancer (32,600 cases, 25.5%), bladder cancer (37,950 cases, 29.7%), and prostate cancer (57,332 cases, 44.8%). The age-standardized incidence rates of prostate cancer showed a significant increase with an APC of 12.3% in males. Kidney cancer gradually increased with an APC of 6.0% for both sexes and became the second most frequent urological cancer after 2008. Bladder cancer showed no significant change with an APC of -0.2% for both sexes and has decreased slightly since 2007. The distribution of kidney cancer according to age showed two peaks in the 50- to 54-year-old and 65- to 69-year-old age groups. Bladder and prostate cancers occurred mostly in the 70- to 74-year-old age group. The proportions of male to female were 2.5:1 in kidney cancer and 5.6:1 in bladder cancer. We have summarized the incidence trends of kidney, bladder, and prostate cancers and have provided useful information for screening and management of these cancers in the future.
                Bookmark

                Author and article information

                Journal
                J Korean Med Sci
                J. Korean Med. Sci
                JKMS
                Journal of Korean Medical Science
                The Korean Academy of Medical Sciences
                1011-8934
                1598-6357
                25 April 2018
                14 May 2018
                : 33
                : 20
                : e145
                Affiliations
                [1 ]Department of Obstetrics and Gynecology, CHA Bundang Medical Center, Seongnam, Korea.
                [2 ]Department of Biostatistics, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
                [3 ]Korea Photonics Technology Institute, Gwangju, Korea.
                [4 ]Department of Medical Equipment, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
                [5 ]Department of Urology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
                Author notes
                Address for Correspondence: Jae Heon Kim, MD, PhD. Department of Urology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, 59 Daesagwan-ro, Yongsan-gu, Seoul 04401, Korea. piacekjh@ 123456schmc.ac.kr

                *Min Jung Baek and Suyeon Park contributed equally to this work.

                Author information
                https://orcid.org/0000-0001-5279-9115
                https://orcid.org/0000-0002-6391-557X
                https://orcid.org/0000-0001-6403-7150
                https://orcid.org/0000-0001-9313-2966
                https://orcid.org/0000-0003-2051-0721
                https://orcid.org/0000-0002-0671-1263
                https://orcid.org/0000-0002-4490-3610
                Article
                10.3346/jkms.2018.33.e145
                5944212
                29760605
                a603a392-353e-45b7-9741-298c0bfa00d3
                © 2018 The Korean Academy of Medical Sciences.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 09 October 2017
                : 26 February 2018
                Funding
                Funded by: National Research Foundation, CrossRef http://dx.doi.org/10.13039/501100003725;
                Award ID: 2015M3D5A1065926
                Funded by: Soonchunhyang University, CrossRef http://dx.doi.org/10.13039/501100002560;
                Categories
                Original Article
                Urology

                Medicine
                prostatic hperplasia,lower uinary tact smptoms,urinary icontinence,urodynamic study,cystoscopy

                Comments

                Comment on this article